Priyanka Kasatkar: How One Research Idea Became a Diagnostic Innovation in Hemostasis
Priyanka Kasatkar, Biomedical researcher in Molecular Biology, Hemostasis and thrombosis, shared a post on LinkedIn:
“An idea written in a PDF project proposal in 2014… became an innovation, then a technology, then diagnostic kits used in the market – and today, a granted patent!
During my PhD, I witnessed patients with bleeding disorders travelling from different parts of India to Mumbai just for diagnosis.
At that time, only a few specialized coagulation centres were available in the country, and many bleeders with Hemophilia A and von Willebrand Disease (VWD) remained undiagnosed or experienced long delays in diagnosis and treatment.
Hemophilia A and VWD were the primary focus of this work because they are among the most common inherited bleeding disorders worldwide.
Lack of awareness and paucity of diagnostic facilities were among the major reasons behind the large number of undiagnosed cases globally.
Seeing the struggles of patients and their families stayed with me deeply.
Somewhere during those years, a simple thought kept coming back to me – ‘What if bleeding disorder patients who urgently need rapid point-of-care (POC) diagnosis could receive faster, simpler, and more accessible testing?’
That thought slowly turned into an idea… and that idea became this innovation.
Today, I am happy to share that our patent has been officially granted in India (Patent No. 588415) by the Indian Patent Office under Indian Council of Medical Research!!
Grateful to ICMR for supporting translational healthcare innovation.
What makes this milestone especially meaningful to me is that this innovation did not remain just a ‘paper patent.’
The diagnostic kits based on this technology have already been in the market for the past 3 years, helping clinicians and contributing toward real-world patient care.
The technology has also received granted patents in India and South Africa.
This journey had everything – years of research, long hours in the lab, experiments, clinical validation, persistence, patience, technology transfer, commercialization, and the continuous effort to translate an idea into something that could genuinely help patients.
Grateful to all those who helped and supported me throughout this journey.
For me, the true purpose of science is not just publications or patents – it is creating solutions that can genuinely improve lives.”
Stay updated with Hemostasis Today.
-
May 13, 2026, 13:09Ram Mohan Jaiswal։ Celebrating International Nurses Day with Voluntary Blood Donation
-
May 13, 2026, 13:05Mohammed VH: Altered INR and Bleeding Risk With Torsemide and Warfarin
-
May 13, 2026, 13:04Nadia Tarhini: Thromboembolic Complications in Pediatric Acute Lymphoblastic Leukemia
-
May 13, 2026, 12:59Steve Schleuder: The Hidden Financial Burden of Living with Chronic Illness
-
May 13, 2026, 12:44Tom Heck: Why Some Gene Therapies Succeed While Others Fail Commercially
-
May 13, 2026, 12:17Abdul Mannan: Optimizing Eltrombopag Response Through Proper Timing
-
May 13, 2026, 12:16Ajay Kumar Yadav: Empowering Healthcare Workers Through Hemophilia Education
-
May 13, 2026, 12:09Sophia Delicou: Modern Approaches to Transfusion Support During Pregnancy
-
May 13, 2026, 07:35Ifeanyichukwu Ifechidere: Why DIC is the Condition That Humbles even the Most Experienced Scientists